Multiple Myeloma: present facts and future expectations

Multiple Myeloma: present facts and future expectations
The 10th Anniversary of Polish Myeloma Study Group
May 21-23, 2015
Lublin, Poland
Honour Committee:
Rector of the Medical University of Lublin: Prof. Andrzej Drop
Marshal of the Lubelskie Voivodeship: Sławomir Sosnowski
Mayor of the City of Lublin: Krzysztof Żuk
Scientific Committee:
Prof. Anna Dmoszyńska - chair
Prof. Aleksander Skotnicki
Prof. Wiesław W. Jędrzejczak
Prof. Lidia Usnarska-Zubkiewicz
Prof. Tadeusz Robak
Prof. Jan Walewski
Organizing Committe
Prof. Krzysztof Giannopoulos - chair
Prof. Marek Hus
Dr Adam Walter-Croneck,
Dr Paulina Własiuk
Thursday – May 21st , 2015
20.00 Welcome dinner
Friday – May 22nd , 2015
8.30-8.45 Welcome address and short history of Polish Myeloma Study Group –
Anna Dmoszyńska
8.45 – 10.15 Short presentation of European Myeloma Study Groups
Chairmen: Heinz Ludwig (Austria), Tadeusz Robak (Poland)
IFM - Intergroupe Francophone du Myelome Group - Philippe Moreau (France)
PETHEMA (Programa para el Estudio y la Terapéutica de las Hemopatías Malignas)
Group – Maria Victoria Mateos (Spain)
Central European Myeloma Study Group – Heinz Ludwig (Austria)
The Nordic Myeloma Group – Torben Plesner (Denmark)
EBMT Group - Gosta Gahrton (Sweden)
HOVON (The Haemato Oncology Foundation for Adults in the Netherlands) Group –
Pieter Sonneveld (Netherlands)
The Greek Myeloma Study Group – Evangelos Terpos (Greece)
The Czech Myeloma Group – Roman Hajek (Czech Republik)
10.15-10.45 Coffee break
10.45 – 12.15 Short presentation of Polish Myeloma Study Group achievements
Chairmen: Anna Dmoszyńska (Poland), Aleksander Skotnicki (Poland)
Value of cytogenetic assessment in treatment decisions and prognostification: on
behalf of Polish Myeloma Study Group Norbert Grząśko (20 minutes)
Multicenter clinical trials: Induction therapy with cyclophosphamide, thalidomide and
dexamethasone in Poland: on behalf of Polish Myeloma Study Group Adam WalterCroneck (10 minutes)
Bortezomib-based regiment for relapsed/refractory multiple myeloma patients: on
behalf of Polish Myeloma Study Group Adam Walter-Croneck, – (15 minutes),
Lenalidomide-based therapy for multiple myeloma patients – Polish experience: on
behalf of Polish Myeloma Study Group Lidia Usnarska-Zubkiewicz (15 minutes)
Immune defects in multiple myeloma: on behalf of Polish Myeloma Study Group
Krzysztof Giannopoulos (15 minutes)
12.15-13.45 Satellite session I
13.45 -14.45 Lunch
14.45 – 15.45 Satellite session II
15.45. – 16.45 Expert Panel I – The role of cytogenetic abnormalities in the
treatment decisions
Chair: Phillipe Moreau, Participants: Pieter Sonneveld, Roman Hajek , Anna
Dmoszyńska, Tomasz Wróbel, Olga Haus, Dominik Dytfeld
16.45-17.00 Coffee break
17.00. – 18.00 Expert Panel II – Bone lesions: diagnosis and treatment
Chair: Evangelos Terpos, Participants: Maria Victoria Mateos, Torben Plesner,
Lidia Usnarska-Zubkiewicz, Artur Jurczyszyn, Iwona Hus, Bogdan Małkowski
19.30 the Concert at Old Theatre in Old City of Lublin
20.30 Dinner
Saturday – May 23th , 2015
8.30 – 10.00 Expert Panel III – Multiple myeloma: the current knowledge and
future perspectives
Chair: Gosta Gahrton, Participants: Philippe Moreau, Heinz Ludwig, Wiesław
Wiktor Jędrzejczak, Krzysztof Giannopoulos, Krzysztof Jamroziak, Jerzy
Hołowiecki, Andrzej Jakubowiak
10.00-11.00 Satellite session III
11.00 -12.00 Plans for Cooperation:
Carfilzomib – rationale option for relapsed/refractory multiple myeloma Andrzej Jakubowiak
Consolidation with carfilzomib, lenalidomide and dexamethasone after
autologous stem cell transplantation: multicentre research proposal of Polish
Myeloma Consortium – Dominik Dytfeld
End of the meeting